Do Biotech Investors stick to their Home Market?

It is no surprise that most biotech investors are based in the US. But, do they invest exclusively in American companies? Read the report Would you like to be notified about new articles, reports and other valuable content published by Venture Valuation?

Read more

Interview with Braizon Therapeutics

Applying intelligently glycemic control and a systematic route through the BBB (blood-brain barrier) to effectively reach neurons. Venture Valuation (VV) interviewed the CEO, Mariko Tosu, PhD

Read more

Whitepaper: Life Sciences – 409A valuation vs. valuation to raise money

The US Internal Revenue Code has numerous regulations which must be adhered to in order for companies to reach compliance standards. One such regulation, Section 409A of the IRC, governs the complexities of setting strike prices for employee stock options and requires that companies be properly audited before issuing stock options as employee compensation. Often … Continue reading Whitepaper: Life Sciences – 409A valuation vs. valuation to raise money

Read more

Biotechgate announces the launch of a clinical trial database

Zurich, 25th March 2019 Biotechgate announces the launch of a clinical trial database with more than 460,000 trial records. Clinical trial data is imported from more than 13 registries around the world and continuously updated and catalogued. Thanks to the use of newly developed smart software components, the data is presented in a well-structured and … Continue reading Biotechgate announces the launch of a clinical trial database

Read more

Whitepaper: Collaboration of Venture Valuation and Ferring Pharmaceuticals

Switzerland, March 2019: Venture Valuation has been working with Ferring Pharmaceutical supporting the company with external, third-party product/asset valuations of potential in-licensing opportunities. After Ferring had identified a specific opportunity and deemed interesting to move it forward in the internal evaluation process, Venture Valuation was mandated to review the product/opportunity from an external point of … Continue reading Whitepaper: Collaboration of Venture Valuation and Ferring Pharmaceuticals

Read more

Interviews with leading Life Sciences companies: Ava AG

Inspired by co-founder Lea von Bidder’s concept, the Ava bracelet is becoming an indispensable device for women to monitor their own biological rhythms. Venture Valuation (VV) interviewed Vicky Kummer, Global Brand Manager. Read the interview Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?

Read more